Lars Giger

This inventor holds 18 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Novozymes A/s, The Procter Gamble Company, Henkel Ag & Company, Kgaa. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lars Giger. Retrieved from https://idiyas.com/inventor/lars-giger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 2)

% Patents Active = 94.4

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 13)

Average Co-Inventor Count = 8.1

ph-index = 2

Forward Citations = 19(Granted Patents)

Company Filing History:

The Procter Gamble Company

patents

1 out of 4,538

Henkel Ag & Company, Kgaa

patents

Years Active: 2020-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE51046 - Polypeptide Variants (2026-09-29),

2. 12686857 - Dnase Variants (2026-07-21),

3. 12590273 - STABILIZED GLYCOSIDE HYDROLASE VARIANTS (2026-03-31),

4. 12391934 - Stabilized cellulase variants (2025-08-19),

5. 12129498 - Stabilized endoglucanase variants (2024-10-29),

6. 12116553 - Polypeptide variants (2024-10-15),

7. 11795418 - GH9 endoglucanase variants and polynucleotides encoding same (2023-10-24),

8. 11661592 - Stabilized endoglucanase variants (2023-05-30),

9. 11566239 - Stabilized cellulase variants (2023-01-31),

10. 11447723 - Polypeptide variants (2022-09-20),

11. 11441136 - DNase variants (2022-09-13),

12. 11384347 - Alpha-amylase variants and polynucleotides encoding same (2022-07-12),

13. 11352592 - Polypeptide variants (2022-06-07),

14. 11072765 - GH9 endoglucanase variants and polynucleotides encoding same (2021-07-27),

15. 10988747 - Detergent composition comprising GH9 endoglucanase variants I (2021-04-27),

Title: Innovations by Lars Giger: A Pioneer in Cellulase Variants

Introduction

Lars Giger is a notable inventor based in Valby, Denmark, recognized for his significant contributions to the field of enzymatic innovations. With a total of 15 patents to his name, Giger has made remarkable advancements, particularly in the development of cellulase variants that enhance laundry applications.

Latest Patents

Among his latest patents are the "Stabilized cellulase variants," which disclose variants of a cellulase exhibiting improved stability in the presence of a protease. This innovation is particularly useful in laundry applications, ensuring that the cellulase remains effective even when exposed to proteolytic enzymes. Another significant patent is the "Stabilized endoglucanase variants," which similarly focus on enhancing the stability of cellulase variants for laundry use.

Career Highlights

Throughout his career, Lars Giger has worked with prominent companies such as Novozymes A/S and The Procter & Gamble Company. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to the advancement of enzymatic solutions in various industries.

Collaborations

Giger has collaborated with esteemed colleagues, including Lars Henrik Oestergaard and Annette Helle Johansen. These partnerships have fostered a creative environment that has led to the development of groundbreaking technologies in the field of cellulases.

Conclusion

Lars Giger's contributions to the field of enzymatic innovations, particularly through his patented cellulase variants, highlight his role as a leading inventor. His work continues to influence the laundry industry and beyond, showcasing the importance of innovation in practical applications.

Profile summary based on public USPTO records.